Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PhenixFIN (PFX) Cash & Equivalents (2021 - 2025)

PhenixFIN (PFX) has disclosed Cash & Equivalents for 5 consecutive years, with $3.4 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 52.6% to $3.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.4 million through Dec 2025, down 52.6% year-over-year, with the annual reading at $7.3 million for FY2025, 89.21% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $3.4 million at PhenixFIN, down from $7.3 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $67.6 million in Q3 2024, with the low at $3.4 million in Q4 2025.
  • Average Cash & Equivalents over 5 years is $19.5 million, with a median of $10.9 million recorded in 2023.
  • The sharpest move saw Cash & Equivalents soared 1028.41% in 2024, then tumbled 89.21% in 2025.
  • Over 5 years, Cash & Equivalents stood at $59.4 million in 2021, then crashed by 70.27% to $17.7 million in 2022, then crashed by 31.04% to $12.2 million in 2023, then plummeted by 40.96% to $7.2 million in 2024, then plummeted by 52.6% to $3.4 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $3.4 million, $7.3 million, and $7.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.